Detalhe da pesquisa
1.
Efficacy and safety of high-dose etoposide cytarabine as consolidation following rituximab methotrexate temozolomide induction in newly diagnosed primary central nervous system lymphoma in immunocompetent patients.
Haematologica
; 103(7): e296-e299, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29472354
2.
Maximizing the Clinical Benefit of Radiotherapy in Solitary Plasmacytoma: An International Multicenter Analysis.
Cancers (Basel)
; 12(3)2020 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32183106
3.
Prognostic value of early 18F-FDG PET scanning evaluation in immunocompetent primary CNS lymphoma patients.
Oncotarget
; 9(24): 16822-16831, 2018 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-29682187
4.
Advances in targeted therapy for the treatment of patients with relapsed/refractory multiple myeloma.
Expert Rev Hematol
; 9(1): 91-105, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26558304
5.
Risk factors, clinical features, and outcome of Pseudomonas aeruginosa bacteremia in patients with hematologic malignancies: a case-control study.
Am J Infect Control
; 41(6): 527-30, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23219670
6.
Our experience of solitary plasmacytoma of the bone: improved PFS with a short-course treatment by IMiDs or proteasome inhibitors combined with intensity-modulated radiotherapy.
Leuk Lymphoma
; 59(7): 1756-1758, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29087212